Loading organizations...
Key people at Haoyue Capital.
Haoyue Capital was founded in 2013 by Liu Hao (Founder & CEO).
Haoyue Capital operates as an investment bank, providing financial advisory and investment management services exclusively for China's healthcare sector. The firm specializes in private placements, mergers, acquisitions, and reorganizations, and manages the Haoyue China Healthcare Fund. Its focus areas include biopharma, medical devices, healthcare services, digital health, and IVD & life sciences.
Established in 2014 by experienced bankers and investment professionals, Haoyue Capital was founded on the insight that China's burgeoning healthcare market required dedicated financial expertise. This specialized background allows the firm to adeptly navigate the sector’s unique complexities and capital requirements.
The firm guides healthcare enterprises through various funding stages, from Series A to pre-IPO, facilitating strategic financing. Haoyue Capital's vision is to empower these companies through comprehensive capital solutions and advisory, delivering distinctive insights and a holistic understanding of China's dynamic healthcare investment landscape.
Key people at Haoyue Capital.
Haoyue Capital was founded in 2013 by Liu Hao (Founder & CEO).
Haoyue Capital has 4 tracked investments across 4 companies. The latest tracked deal is $27.0M Series C in Drug Farm in May 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 16, 2023 | Drug Farm | $27.0M Series C | YD Capital | Betta Capital, Jiashan County State Owned Assets Investment, Wedo Venture Management |
| Feb 6, 2023 | Furong Biotech | $14.7M Series A | — | Co WIN Ventures, Fangfu Venture Capital, Siyang YU |
| Aug 3, 2021 | Pulse | $100.0M Series C | Hillhouse Capital, 何国伟 | Boyu Capital, Insight Capital |
| May 1, 2017 | CANbridge Pharmaceuticals | $25.0M Series B | Lapam Capital | Qiming Venture Partners, Biossom Investment Management, WuXi AppTec, Yanyuan Capital, YuanMing Capital |
